Breast and cervical cancer screening programme implementation in 16 countries.
about
Adherence to recommended health checks by women in mid-life: data from a prospective study of women across Australia.Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions.Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.Introduction of organised mammography screening in Tyrol: results following first year of complete rollout.CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasisEvaluation of breast cancer knowledge among health promoters in Mexico before and after focused training.Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer.New insight into Ki67 expression at the invasive front in breast cancer.Clinical application of DNA ploidy to cervical cancer screening: A review.Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.Predictors of Adherence to Multiple Clinical Preventive Recommendations among Adults with Diabetes in Spain.Cervical cancer screening in the United States and the Netherlands: a tale of two countriesTrends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based studyClinical implications of β-catenin protein expression in breast cancer.High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery.Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.Determinants of breast cancer screening uptake in Kurdish women of IranTrends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands.Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control studyMalpractice claims following screening mammography in The Netherlands.Characteristics and screening outcome of women referred twice at screening mammography.Re-attendance at biennial screening mammography following a repeated false positive recall.Breast cancer in low and middle income countries (LMICs): a shifting tide in global health.WHAT IS THE ROLE OF COMMUNITY PREFERENCE INFORMATION IN HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING? A CASE STUDY OF COLORECTAL CANCER SCREENING.Increased MTHFD2 expression is associated with poor prognosis in breast cancer.MTA1 expression correlates significantly with ER-alpha methylation in breast cancer.Screening outcome in women repeatedly recalled for the same mammographic abnormality before, during and after the transition from screen-film to full-field digital screening mammography.Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study.Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography.National Breast Cancer Screening Programme, Singapore: evaluation of participation and performance indicators.Participation rates for organized colorectal cancer screening programmes: an international comparison.Clinical implications of CIP2A protein expression in breast cancer.Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.Mammographic screening programmes in Europe: organization, coverage and participation.
P2860
Q30748056-65A7ECD4-921F-47C2-9185-E49CDAF31926Q33578364-0BD9799F-3A4A-4472-AB54-D228159D7545Q33800383-158C1FB3-8C70-4798-99B8-D5832C94F4CCQ34005951-4174C83A-BCF2-4138-87BC-FF803327C9C3Q34151630-B1E3ADB4-A983-4DFF-AF7B-CAD21FBCB0E5Q34359282-061D2FF0-CC04-4AF6-B8D7-73B93C3E6AEAQ34441826-877FC2BA-DAE1-4D23-8DB0-4CF533EBF5B2Q34575792-72B1BB85-3C79-4E18-957C-036BABD41584Q34657755-9646D6BB-B388-4386-9A8B-F8CDC76BFC08Q35125812-081484A2-710A-4587-B86C-A1A1D2A9B5CEQ35677363-931A76F8-EB2C-46C4-8722-75A6DE53E98DQ36063746-7F006B5A-7723-4094-AB72-8C881FA3B60DQ36393123-C81F72D3-EEF5-40B0-8177-E9716A043DDEQ36464753-07FB4E52-9DE1-4B12-978B-8ABAC9645FC3Q36557288-CC8CD2F4-A9A3-44BD-84CA-50859113EB71Q36746804-79468FFF-7E8A-40FD-937A-A2078CF0E8CDQ36841911-FA5BE2E8-2257-4263-969E-EBB98961DA3DQ37003278-B61935D4-4F52-4A7E-AD6E-6E08C7DD8094Q37477943-C2391628-8B44-4D90-B703-56D461EC22DFQ37968969-13DEE76D-992C-4F9B-A63C-52AD8589D675Q38018568-9F242504-792F-45A1-A7A5-236468A4AA28Q38205744-04AE14BE-5EBE-4D99-BA8C-59A49335F73CQ38393643-079D942B-A3CD-43E9-AF37-0FF272A2ABC8Q38588003-1E8D5CB0-F077-4D7A-B801-6956D273A392Q39185369-8F78049E-9076-4D7E-9A18-94A0E3AED65CQ39340427-8CF410CD-4A3B-4783-9934-DE55CB900148Q39765500-EFC916B4-C471-4D1C-9C5F-DD98F9D8369DQ40045057-154D0AFD-1BC0-438A-B66B-7BDB92BD5F7AQ40106617-6A6328CE-4EEA-4848-B0F4-5FF11C1EAD51Q40388119-1A5E4CD2-10C3-48E3-8D43-EE9230E98744Q40829595-B9A688A2-B11D-44FB-80A5-D7E16869A341Q40947126-3A4A29FC-52B9-40B1-AF8E-0D739E7999DDQ43448302-B653B3D0-37AF-43D6-A199-852D24E5DDD3Q44433466-A4557B03-A342-46D3-90C4-D93CABE427FAQ45328273-E67A43CF-EA92-4A63-BBC9-4667B79E62F5
P2860
Breast and cervical cancer screening programme implementation in 16 countries.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Breast and cervical cancer screening programme implementation in 16 countries.
@en
Breast and cervical cancer screening programme implementation in 16 countries.
@nl
type
label
Breast and cervical cancer screening programme implementation in 16 countries.
@en
Breast and cervical cancer screening programme implementation in 16 countries.
@nl
prefLabel
Breast and cervical cancer screening programme implementation in 16 countries.
@en
Breast and cervical cancer screening programme implementation in 16 countries.
@nl
P2093
P2860
P356
P1476
Breast and cervical cancer screening programme implementation in 16 countries.
@en
P2093
Carrie Klabunde
Emily C Dowling
International Cancer Screening Network (ICSN)
P2860
P304
P356
10.1258/JMS.2010.010033
P577
2010-01-01T00:00:00Z